sulconazole has been researched along with Mycoses in 2 studies
sulconazole: RN given refers to cpd with unspecified isomeric designation; structure given in first source
sulconazole : A racemate comprising equimolar amounts of (R)- and (S)-sulconazole. An antifungal agent with activity against Candida species, it is used (generally as the nitrate salt) for the topical treatment of fungal skin infections.
1-{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole : A member of the class of imidazoles that is 1-ethyl-1H-imidazole in which one of the hydrogens of the methyl group is replaced by a (4-chlorobenzyl)sulfanediyl group while a second is replaced by a 2,4-dichlorophenyl group.
Mycoses: Diseases caused by FUNGI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samee, A | 1 |
| Usman, F | 1 |
| Wani, TA | 1 |
| Farooq, M | 1 |
| Shah, HS | 1 |
| Javed, I | 1 |
| Ahmad, H | 1 |
| Khan, R | 1 |
| Zargar, S | 1 |
| Kausar, S | 1 |
| Beauvais, A | 1 |
2 other studies available for sulconazole and Mycoses
| Article | Year |
|---|---|
Sulconazole-Loaded Solid Lipid Nanoparticles for Enhanced Antifungal Activity: In Vitro and In Vivo Approach.
Topics: Animals; Antifungal Agents; Delayed-Action Preparations; Drug Carriers; Mycoses; Nanoparticles; Part | 2023 |
[Action of sulconazole on fungal membrane].
Topics: Antifungal Agents; Cell Membrane; Chitin Synthase; Fungi; Glucosyltransferases; Humans; Imidazoles; | 1991 |